BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2851784)

  • 1. Silent human pancreatic glucagonoma and "A" nesidioblastosis.
    Balas D; Senegas-Balas F; Delvaux M; Bertrand C; Fagot-Revurat P; Rumeau JL; Ribet A
    Pancreas; 1988; 3(6):734-9. PubMed ID: 2851784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A malignant tumor of the pancreas producing glucagonoma syndrome: immunocytochemistry and ultrastructure of liver metastases and comparison with the primary tumor.
    Bani D; Bani Sacchi T; Biliotti G
    Pancreas; 1989; 4(4):492-5. PubMed ID: 2548178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagonomas. Ultrastructure and immunocytochemistry.
    Warner TF; Block M; Hafez GR; Mack E; Lloyd RV; Bloom SR
    Cancer; 1983 Mar; 51(6):1091-6. PubMed ID: 6295622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron microscopic and immunoelectron microscopic demonstration of pancreatic polypeptide cells in glucagonoma: colocalization of pancreatic peptide and glucagon in single secretory granules.
    Ooi A; Katsuda S; Nakanishi I; Kameya T; Yamaguchi K; Kitamura H; Hayakawa Y
    Ultrastruct Pathol; 1989; 13(1):15-22. PubMed ID: 2537546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glucagon-secreting pancreatic alpha islet cell tumor presenting as spinal cord compression.
    Staren ED; Steinecker GA; Gould VE
    J Surg Oncol; 1987 Aug; 35(4):249-52. PubMed ID: 3039255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets.
    Petraki CD; Karavana VN; Revelos KI; Luo LY; Diamandis EP
    Histochem J; 2002; 34(6-7):313-22. PubMed ID: 12769263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
    Bani D; Bani Sacchi T; Biliotti G
    Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
    Elsborg L; Glenthøj A
    Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
    Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
    Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory granules in benign and malignant glucagonomas of the pancreas.
    Nakanishi I; Katsuda S; Kajikawa K; Yonemura Y; Konishi K; Miwa K
    Acta Pathol Jpn; 1984 Jan; 34(1):95-102. PubMed ID: 6328864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagonoma presenting as morbid obesity.
    Martin FM; Hamilton W; Dons R; Cashell AW; Ghosh BC
    J Surg Oncol; 1988 Dec; 39(4):256-9. PubMed ID: 2848156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic tumor with diabetes and necrotic migratory erythema. Glucagonoma or proglucagonoma?].
    Gillet M; Rodier C; Quencez E; Laurent R; Mantion G; Landecy G; Nguyen N; Carbillet JP
    Chirurgie; 1988; 114(5):441-6. PubMed ID: 2852092
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.
    Ahlman H; Ahlund L; Dahlström A; Grimelius L; Theodorsson E
    J Surg Oncol; 1990 Jul; 44(3):191-9. PubMed ID: 2164620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
    White A; Tan K; Gray C; Roberts I; Ratcliffe JG
    Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nesidioblastosis coexisting with islet cell tumor and intraductal papillary mucinous hyperplasia.
    Zhao X; Stabile BE; Mo J; Wang J; French SW
    Arch Pathol Lab Med; 2001 Oct; 125(10):1344-7. PubMed ID: 11570912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.